Journal Articles Médecine et Maladies Infectieuses Year : 2019

Nationwide survey of hospital antibiotic stewardship programs in France

Abstract

OBJECTIVE: We aimed to evaluate the current state of antibiotic stewardship (ABS) in French public and private acute care hospitals.METHODS: We conducted a cross-sectional online questionnaire survey. The selection of participating hospitals was performed through a stratified random sampling procedure among all French public and private hospitals with acute care beds.RESULTS: 97/215 (45%) hospitals participated. A formal ABS program was implemented in 84% (80/95) of hospitals. A person officially in charge of this program (i.e., ABS program leader) was present in almost all participating hospitals (99%, 95/96) and s/he coordinated a multidisciplinary ABS team in 42% (40/96) of cases. The median time spent on ABS activities was 1.7, 1.6, and 0.8hours/week/100 acute care beds for infectious disease (ID) specialists, pharmacists, and microbiologists respectively; 27% (7/26) of ID specialists/other clinicians, 58% (15/26) of pharmacists, and 80% (16/20) of microbiologists received no salary support for the stewardship activities conducted as part of the team. Local guidelines (94%, 88/94), electronic medical records (85%, 80/94), and an antibiotic restriction policy (92%, 82/89) were implemented in almost all hospitals. Reports on antibiotic consumption and local resistance rates were available in 100% (91/91) and 84% (76/91) of hospitals, respectively.CONCLUSION: Despite the existence of national requirements, hospital ABS programs are not fully implemented in France, mainly because of inadequate institutional support and funding.
Fichier principal
Vignette du fichier
S0399077X18308278.pdf (521) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-02458335 , version 1 (22-08-2022)

Licence

Identifiers

Cite

F. Binda, G. Tebano, M.C. Kallen, J. ten Oever, M.E. Hulscher, et al.. Nationwide survey of hospital antibiotic stewardship programs in France. Médecine et Maladies Infectieuses, 2019, 50 (5), pp.414-422. ⟨10.1016/j.medmal.2019.09.007⟩. ⟨hal-02458335⟩
75 View
113 Download

Altmetric

Share

More